home / stock / pgen / pgen quote
Last: | $1.40 |
---|---|
Change Percent: | -2.14% |
Open: | $1.43 |
Close: | $1.40 |
High: | $1.44 |
Low: | $1.33 |
Volume: | 753,657 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.4 | $1.43 | $1.4 | $1.44 | $1.33 | 753,657 | 05-02-2024 |
$1.4 | $1.34 | $1.4 | $1.455 | $1.31 | 683,622 | 05-01-2024 |
$1.32 | $1.39 | $1.32 | $1.41 | $1.31 | 496,540 | 04-30-2024 |
$1.4 | $1.41 | $1.4 | $1.4594 | $1.4 | 381,256 | 04-29-2024 |
$1.41 | $1.4 | $1.41 | $1.44 | $1.39 | 413,594 | 04-26-2024 |
$1.4 | $1.4 | $1.4 | $1.41 | $1.37 | 611,778 | 04-25-2024 |
$1.42 | $1.4 | $1.42 | $1.43 | $1.39 | 558,930 | 04-24-2024 |
$1.4 | $1.4 | $1.4 | $1.45 | $1.39 | 506,972 | 04-23-2024 |
$1.38 | $1.32 | $1.38 | $1.39 | $1.32 | 890,547 | 04-22-2024 |
$1.33 | $1.3 | $1.33 | $1.34 | $1.28 | 1,013,420 | 04-19-2024 |
$1.32 | $1.3 | $1.32 | $1.355 | $1.28 | 1,120,032 | 04-18-2024 |
$1.31 | $1.39 | $1.31 | $1.405 | $1.3 | 811,216 | 04-17-2024 |
$1.36 | $1.41 | $1.36 | $1.42 | $1.33 | 847,870 | 04-16-2024 |
$1.4 | $1.4 | $1.4 | $1.42 | $1.37 | 1,223,162 | 04-15-2024 |
$1.42 | $1.43 | $1.42 | $1.44 | $1.375 | 932,148 | 04-12-2024 |
$1.45 | $1.44 | $1.45 | $1.4775 | $1.42 | 695,083 | 04-11-2024 |
$1.41 | $1.35 | $1.41 | $1.41 | $1.33 | 1,254,327 | 04-10-2024 |
$1.41 | $1.41 | $1.41 | $1.46 | $1.4 | 313,606 | 04-09-2024 |
$1.41 | $1.4 | $1.41 | $1.46 | $1.4 | 649,342 | 04-08-2024 |
$1.4 | $1.39 | $1.4 | $1.43 | $1.35 | 515,347 | 04-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Precigen Inc. Company Name:
PGEN Stock Symbol:
NASDAQ Market:
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting PR Newswire GERMANTOWN, Md. , April 24, 2024 /...
Actym Therapeutics Appoints Thomas Smart as CEO PR Newswire BERKELEY, Calif. , April 24, 2024 /PRNewswire/ -- Actym Therapeutics , pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive Off...
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th PR Newswire – Inaugural multi-stakeholder event on June 11th (6/11) will raise awareness and bring together individuals living with RRP,...